Validation of the O3DY French Version (O3DY-F) for the Screening of Cognitive Impairment in Community Seniors in the Emergency Department.


Journal

The Journal of emergency medicine
ISSN: 0736-4679
Titre abrégé: J Emerg Med
Pays: United States
ID NLM: 8412174

Informations de publication

Date de publication:
Jul 2019
Historique:
received: 23 07 2018
revised: 07 02 2019
accepted: 10 02 2019
pubmed: 27 4 2019
medline: 20 5 2020
entrez: 27 4 2019
Statut: ppublish

Résumé

It is recommended that older patients undergo systematic mental status screening when presenting to the emergency department (ED). However, the tools available are not necessarily adapted to the ED environment, therefore, quicker and easier tools are needed. The purpose of this study is to validate the Ottawa 3DY-French (O3DY-F) Scale as a screening tool for delirium and cognitive impairment in a French-speaking cohort. This multicenter prospective study was conducted in four hospitals across the province of Quebec. Inclusion criteria were: age ≥ 65 years, ED stay ≥ 8 h, awaiting admission to a care unit, and independent or semi-independent in their daily living activities. Cognitive status was assessed during the initial interview using the Telephone Interview for Cognitive Screening-modified (TICS-m) and the O3DY-F scale. Comparisons were made between the O3DY-F and the TICS-m and Confusion Assessment Method (CAM) to assess the sensitivity and specificity of the O3DY-F for the detection of cognitive impairment and delirium. A total of 313 patients were included in this study, 139 of which had a positive O3DY-F. When compared with the CAM, the O3DY-F had a sensitivity of 84.2% (95% confidence interval [CI] 60.4-96.6) and a specificity of 58.2% (95% CI 52.3-63.9) for the detection of prevalent delirium. The O3DY-F had a sensitivity of 76.2% (95% CI 66.7-84.8) and a specificity of 67.6% (95% CI 61.0-73.6) for cognitive impairment (defined as a TICS-m < 27). The O3DY-F is a useful and effective tool to screen for delirium and undetected cognitive impairment among a French-speaking cohort in the ED.

Sections du résumé

BACKGROUND BACKGROUND
It is recommended that older patients undergo systematic mental status screening when presenting to the emergency department (ED). However, the tools available are not necessarily adapted to the ED environment, therefore, quicker and easier tools are needed.
OBJECTIVES OBJECTIVE
The purpose of this study is to validate the Ottawa 3DY-French (O3DY-F) Scale as a screening tool for delirium and cognitive impairment in a French-speaking cohort.
METHOD METHODS
This multicenter prospective study was conducted in four hospitals across the province of Quebec. Inclusion criteria were: age ≥ 65 years, ED stay ≥ 8 h, awaiting admission to a care unit, and independent or semi-independent in their daily living activities. Cognitive status was assessed during the initial interview using the Telephone Interview for Cognitive Screening-modified (TICS-m) and the O3DY-F scale. Comparisons were made between the O3DY-F and the TICS-m and Confusion Assessment Method (CAM) to assess the sensitivity and specificity of the O3DY-F for the detection of cognitive impairment and delirium.
RESULTS RESULTS
A total of 313 patients were included in this study, 139 of which had a positive O3DY-F. When compared with the CAM, the O3DY-F had a sensitivity of 84.2% (95% confidence interval [CI] 60.4-96.6) and a specificity of 58.2% (95% CI 52.3-63.9) for the detection of prevalent delirium. The O3DY-F had a sensitivity of 76.2% (95% CI 66.7-84.8) and a specificity of 67.6% (95% CI 61.0-73.6) for cognitive impairment (defined as a TICS-m < 27).
CONCLUSION CONCLUSIONS
The O3DY-F is a useful and effective tool to screen for delirium and undetected cognitive impairment among a French-speaking cohort in the ED.

Identifiants

pubmed: 31023635
pii: S0736-4679(19)30094-0
doi: 10.1016/j.jemermed.2019.02.007
pii:
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

59-65

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Catherine Bédard (C)

Axe Santé des populations et pratiques optimales en santé, Centre de recherche du CHU de Québec, Hôpital de l'Enfant-Jésus, Québec, Canada; Université Laval, Québec, Canada; Centre d'excellence sur le vieillissement de Québec, Québec, Canada; Centre de Recherche sur les Soins et les Services de Première Ligne de l'Université Laval (CERSSPL-UL), Québec, Canada.

Valerie Boucher (V)

Axe Santé des populations et pratiques optimales en santé, Centre de recherche du CHU de Québec, Hôpital de l'Enfant-Jésus, Québec, Canada; Université Laval, Québec, Canada; Centre d'excellence sur le vieillissement de Québec, Québec, Canada; Centre de Recherche sur les Soins et les Services de Première Ligne de l'Université Laval (CERSSPL-UL), Québec, Canada.

Philippe Voyer (P)

Axe Santé des populations et pratiques optimales en santé, Centre de recherche du CHU de Québec, Hôpital de l'Enfant-Jésus, Québec, Canada; Université Laval, Québec, Canada; Centre d'excellence sur le vieillissement de Québec, Québec, Canada; Centre de Recherche sur les Soins et les Services de Première Ligne de l'Université Laval (CERSSPL-UL), Québec, Canada.

Krishan Yadav (K)

Université Laval, Québec, Canada; Ottawa Hospital Research Institute, Ottawa, ON, Canada; The Ottawa Hospital, Ottawa, ON, Canada.

Debra Eagles (D)

Ottawa Hospital Research Institute, Ottawa, ON, Canada; The Ottawa Hospital, Ottawa, ON, Canada.

Alexandra Nadeau (A)

Axe Santé des populations et pratiques optimales en santé, Centre de recherche du CHU de Québec, Hôpital de l'Enfant-Jésus, Québec, Canada; Université Laval, Québec, Canada; Centre d'excellence sur le vieillissement de Québec, Québec, Canada; Centre de Recherche sur les Soins et les Services de Première Ligne de l'Université Laval (CERSSPL-UL), Québec, Canada.

Pierre-Hugues Carmichael (PH)

Centre d'excellence sur le vieillissement de Québec, Québec, Canada.

Mathieu Pelletier (M)

Université Laval, Québec, Canada; Centre d'excellence sur le vieillissement de Québec, Québec, Canada; Centre de Recherche sur les Soins et les Services de Première Ligne de l'Université Laval (CERSSPL-UL), Québec, Canada; Ottawa Hospital Research Institute, Ottawa, ON, Canada; The Ottawa Hospital, Ottawa, ON, Canada; Centre Intégré de Santé et de Services Sociaux de Lanaudière, Centre Hospitalier Régional de Lanaudière, Saint-Charles-Borromée, QC, Canada.

Emilie Gouin (E)

Centre Hospitalier Régional de Trois-Rivières, Trois-Rivières, QC, Canada.

Simon Berthelot (S)

Axe Santé des populations et pratiques optimales en santé, Centre de recherche du CHU de Québec, Hôpital de l'Enfant-Jésus, Québec, Canada; Université Laval, Québec, Canada.

Raoul Daoust (R)

Centre de recherche de l'Hôpital du Sacré-Cœur de Montréal, Montréal, Canada; Université de Montréal, Montréal, Canada.

Antoine Laguë (A)

Axe Santé des populations et pratiques optimales en santé, Centre de recherche du CHU de Québec, Hôpital de l'Enfant-Jésus, Québec, Canada; Université Laval, Québec, Canada; Centre d'excellence sur le vieillissement de Québec, Québec, Canada; Centre de Recherche sur les Soins et les Services de Première Ligne de l'Université Laval (CERSSPL-UL), Québec, Canada.

Anne-Julie Gagné (AJ)

Axe Santé des populations et pratiques optimales en santé, Centre de recherche du CHU de Québec, Hôpital de l'Enfant-Jésus, Québec, Canada; Université Laval, Québec, Canada; Centre d'excellence sur le vieillissement de Québec, Québec, Canada; Centre de Recherche sur les Soins et les Services de Première Ligne de l'Université Laval (CERSSPL-UL), Québec, Canada.

Marcel Émond (M)

Axe Santé des populations et pratiques optimales en santé, Centre de recherche du CHU de Québec, Hôpital de l'Enfant-Jésus, Québec, Canada; Université Laval, Québec, Canada; Centre d'excellence sur le vieillissement de Québec, Québec, Canada; Centre de Recherche sur les Soins et les Services de Première Ligne de l'Université Laval (CERSSPL-UL), Québec, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH